Considerations When Managing Heart Failure during the COVID-19 Pandemic-Consensus from the Taiwan Society of Cardiology

Kun-Chang Lin; Chun-Chieh Wang; Wei-Chun Huang; Juey-Jen Hwang

doi:10.6515/ACS.202103_37(2).20200916A

Considerations When Managing Heart Failure during the COVID-19 Pandemic-Consensus from the Taiwan Society of Cardiology

Acta Cardiol Sin. 2021 Mar;37(2):125-129. doi: 10.6515/ACS.202103_37(2).20200916A.

Authors

Kun-Chang Lin¹, Chun-Chieh Wang², Wei-Chun Huang^{1

3

4}, Juey-Jen Hwang^{5

6}

Affiliations

¹ Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung.
² Division of Cardiology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan.
³ School of Medicine, National Yang-Ming University, Taipei.
⁴ Department of Physical Therapy, Fooyin University, Kaohsiung.
⁵ Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei.
⁶ National Taiwan University Hospital Yulin Branch, Yulin, Taiwan.

Abstract

Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since December 2019. Acute heart failure has accounted for 23-24% of the initial presentations in patients with COVID-19 infection. Furthermore, COVID-19 might increase metabolic demand and cause acute decompensation of pre-existing stable heart failure. These patients are thus more susceptible to the evolution of more serious clinical symptoms and a higher mortality rate. Given the lack of knowledge about this new disease, this review provides recommendations for the management of heart failure during the COVID-19 pandemic in Taiwan.

Keywords: COVID-19; Heart failure; SARS-CoV-2.

Publication types

Review